Total Payments
$89,552
2024 Payments
$48,297
Companies
5
Transactions
83
Payment Breakdown by Category
Other$46,131 (51.5%)
Consulting$34,885 (39.0%)
Travel$4,457 (5.0%)
Food & Beverage$4,046 (4.5%)
Education$33.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,131 | 8 | 51.5% |
| Consulting Fee | $34,885 | 12 | 39.0% |
| Travel and Lodging | $4,457 | 18 | 5.0% |
| Food and Beverage | $4,046 | 36 | 4.5% |
| Education | $33.80 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $50,263 | 24 | $0 (2024) |
| Mirum Pharmaceuticals, Inc. | $28,881 | 41 | $0 (2024) |
| ALBIREO PHARMA, INC. | $10,375 | 9 | $0 (2024) |
| Retrophin, Inc. | $27.80 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,297 | 37 | Ipsen Biopharmaceuticals, Inc ($32,923) |
| 2023 | $38,613 | 32 | Ipsen Biopharmaceuticals, Inc ($17,339) |
| 2022 | $2,609 | 5 | ALBIREO PHARMA, INC. ($2,438) |
| 2020 | $6.00 | 4 | Travere Therapeutics, Inc. ($6.00) |
| 2019 | $5.39 | 4 | Retrophin, Inc. ($5.39) |
| 2018 | $22.41 | 1 | Retrophin, Inc. ($22.41) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Alagille syndrome | ||||||
| 11/11/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Alagille syndrome | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,569.00 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $368.60 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $335.61 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Alagille syndrome | ||||||
| 11/06/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $138.81 | General |
| Category: Alagille syndrome | ||||||
| 11/06/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $94.57 | General |
| Category: Alagille syndrome | ||||||
| 11/06/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: Alagille syndrome | ||||||
| 10/28/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $237.00 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $116.46 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $69.64 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $143.48 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $118.66 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $28.26 | General |
| Category: Alagille syndrome | ||||||
| 05/30/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,887.00 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $445.93 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $183.27 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $179.84 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $129.54 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Alagille syndrome | ||||||
| 04/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Alagille syndrome | ||||||
About Dr. Shari Sheflin-Findling, DO
Dr. Shari Sheflin-Findling, DO is a Pediatrics healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1831323286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shari Sheflin-Findling, DO has received a total of $89,552 in payments from pharmaceutical and medical device companies, with $48,297 received in 2024. These payments were reported across 83 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,131).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Gastroenterology
- Location New Hyde Park, NY
- Active Since 05/13/2009
- Last Updated 07/21/2022
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1831323286
Products in Payments
- Bylvay (Drug) $60,638
- Livmarli (Drug) $28,881
- (820) Cholbam (Drug) $33.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in New Hyde Park
Vijaya Soma
Pediatrics — Payments: $8,403
Pediatrics $8,403
Michelle Ramos, Np, NP
Pediatrics — Payments: $6,102
Pediatrics $6,102
Dr. Lauren Macaluso, M.d, M.D
Pediatrics — Payments: $3,757
Pediatrics $3,757
Dr. Lynn Hawkins, M.d.,Ph.d, M.D.,PH.D
Pediatrics — Payments: $3,626
Pediatrics $3,626
Jenice Chummar
Pediatrics — Payments: $2,572
Pediatrics $2,572
Dr. Randy Alevi, D.o, D.O
Pediatrics — Payments: $2,336
Pediatrics $2,336